D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 105 Citations 52,623 658 World Ranking 3913 National Ranking 137

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Disease

The scientist’s investigation covers issues in Internal medicine, Rheumatoid arthritis, Physical therapy, Rheumatology and Clinical trial. His research investigates the connection between Internal medicine and topics such as Gastroenterology that intersect with issues in Kappa and External validation. His Rheumatoid arthritis research includes themes of Placebo, Randomized controlled trial, Surgery and Arthritis.

His studies in Physical therapy integrate themes in fields like Epidemiology, Research design, Alternative medicine, Rheumatism and Severity of illness. The concepts of his Rheumatology study are interwoven with issues in Disease activity, Observational study, Cohort and Family medicine. He combines subjects such as Low back pain, Physical medicine and rehabilitation, Clinical research and Set with his study of Clinical trial.

His most cited work include:

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update (3425 citations)
  • Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2665 citations)
  • AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. (1178 citations)

What are the main themes of his work throughout his whole career to date?

Maarten Boers mainly investigates Internal medicine, Rheumatoid arthritis, Physical therapy, Clinical trial and Rheumatology. The study incorporates disciplines such as Gastroenterology and Surgery in addition to Internal medicine. His work deals with themes such as Placebo, Disease and Arthritis, which intersect with Rheumatoid arthritis.

His studies deal with areas such as Osteoarthritis, Alternative medicine, Intensive care medicine, Construct validity and Severity of illness as well as Physical therapy. His research integrates issues of Psychological intervention, Systematic review, Medical physics and Delphi method in his study of Clinical trial. His Rheumatology research includes elements of Rheumatism, Adverse effect and Family medicine.

He most often published in these fields:

  • Internal medicine (48.15%)
  • Rheumatoid arthritis (44.28%)
  • Physical therapy (34.85%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (48.15%)
  • Rheumatoid arthritis (44.28%)
  • Physical therapy (34.85%)

In recent papers he was focusing on the following fields of study:

His main research concerns Internal medicine, Rheumatoid arthritis, Physical therapy, Clinical trial and Rheumatology. The various areas that Maarten Boers examines in his Internal medicine study include Gastroenterology and Surgery. His work on Prednisolone and Radiography as part of general Surgery study is frequently linked to Cobra, therefore connecting diverse disciplines of science.

His Rheumatoid arthritis study combines topics from a wide range of disciplines, such as Rheumatism, Adverse effect, Disease and Arthritis. His biological study spans a wide range of topics, including Osteoarthritis, Patient-reported outcome, Content validity, Construct validity and Low back pain. His work deals with themes such as Systematic review, Outcomes research, Delphi method and Set, which intersect with Clinical trial.

Between 2015 and 2021, his most popular works were:

  • How to select outcome measurement instruments for outcomes included in a “Core Outcome Set” – a practical guideline (300 citations)
  • Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force (135 citations)
  • Core outcome measurement instruments for clinical trials in nonspecific low back pain (114 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Surgery

Maarten Boers mostly deals with Physical therapy, Rheumatoid arthritis, Internal medicine, Clinical trial and Intensive care medicine. His Physical therapy research is multidisciplinary, incorporating elements of Quality of life, Rheumatism, Construct validity, Severity of illness and Low back pain. His work on Antirheumatic Agents as part of general Rheumatoid arthritis study is frequently linked to In patient, bridging the gap between disciplines.

His Internal medicine study frequently links to other fields, such as Abatacept. The various areas that Maarten Boers examines in his Clinical trial study include Osteoarthritis, Delphi method, Gerontology, Position paper and Research design. His Intensive care medicine research is multidisciplinary, incorporating perspectives in Alternative medicine, Context and Medication adherence.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

Beverley J Shea;Jeremy M Grimshaw;George A Wells;Maarten Boers.
(2007)

4574 Citations

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch.
Annals of the Rheumatic Diseases (2014)

4255 Citations

The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus.

Arianne P. Verhagen;Henrica C.W. de Vet;Robert A. de Bie;Alphons G.H. Kessels.
Journal of Clinical Epidemiology (1998)

2463 Citations

AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews.

Beverley J. Shea;Candyce Hamel;George A. Wells;Lex M. Bouter.
(2009)

1855 Citations

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang.
Arthritis & Rheumatism (2011)

1673 Citations

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

Maarten Boers;Arco C Verhoeven;Harry M Markusse;Mart Afj van de Laar.
The Lancet (1997)

1555 Citations

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

Harm Van Tinteren;Otto S. Hoekstra;Egbert F. Smit;Jan H.A.M. Van Den Bergh.
The Lancet (2002)

1001 Citations

Recommendations for a core set of outcome measures for future Phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III

Nicholas Bellamy;John Kirwan;Maarten Boers;Peter Brooks.
The Journal of Rheumatology (1997)

996 Citations

The OMERACT filter for Outcome Measures in Rheumatology.

M Boers;P Brooks;C V Strand;P Tugwell.
The Journal of Rheumatology (1998)

885 Citations

COBRA Combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention

Robert B. M. Landewé;Maarten Boers;Arco C. Verhoeven;Rene Westhovens.
Arthritis & Rheumatism (2002)

827 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Maarten Boers

Paul Emery

Paul Emery

University of Leeds

Publications: 256

Désirée van der Heijde

Désirée van der Heijde

Leiden University Medical Center

Publications: 213

Maxime Dougados

Maxime Dougados

Hôpital Cochin

Publications: 187

Josef S. Smolen

Josef S. Smolen

Medical University of Vienna

Publications: 181

Robert Landewé

Robert Landewé

University of Amsterdam

Publications: 170

Tore K. Kvien

Tore K. Kvien

University of Oslo

Publications: 162

Peter Tugwell

Peter Tugwell

University of Ottawa

Publications: 160

Laure Gossec

Laure Gossec

Sorbonne University

Publications: 154

Daniel Aletaha

Daniel Aletaha

Medical University of Vienna

Publications: 132

Mikkel Østergaard

Mikkel Østergaard

University of Copenhagen

Publications: 131

Robin Christensen

Robin Christensen

University of Southern Denmark

Publications: 128

Bernard Combe

Bernard Combe

University of Montpellier

Publications: 117

Bruno Fautrel

Bruno Fautrel

Université Paris Cité

Publications: 114

Vibeke Strand

Vibeke Strand

Stanford University

Publications: 111

Yoshiya Tanaka

Yoshiya Tanaka

University of Occupational and Environmental Health Japan

Publications: 110

Philip G. Conaghan

Philip G. Conaghan

University of Leeds

Publications: 108

Trending Scientists

Margaret Martonosi

Margaret Martonosi

Princeton University

Daan Wierstra

Daan Wierstra

DeepMind (United Kingdom)

Homer Rahnejat

Homer Rahnejat

Loughborough University

Deepak Pant

Deepak Pant

Flemish Institute for Technological Research

Yunzhi Yang

Yunzhi Yang

Stanford University

A.H.C. van Bruggen

A.H.C. van Bruggen

University of Florida

Renato Gennaro

Renato Gennaro

University of Trieste

Craig M. Bethke

Craig M. Bethke

Aqueous Solutions

Kenneth R. Sperber

Kenneth R. Sperber

Lawrence Livermore National Laboratory

Toshihisa Matsui

Toshihisa Matsui

Goddard Space Flight Center

Guan Le

Guan Le

Goddard Space Flight Center

Michael Schatz

Michael Schatz

Kaiser Permanente

Lucy Berliner

Lucy Berliner

University of Washington

Motoki Iwasaki

Motoki Iwasaki

National Cancer Research Institute, UK

Kathleen Mullan Harris

Kathleen Mullan Harris

University of North Carolina at Chapel Hill

Henrik Spoon

Henrik Spoon

Cornell University

Something went wrong. Please try again later.